Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luka Brcic

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
Frontiers in Medicine|April 23, 2025
Editorial: Biomarkers for progressive pulmonary fibrosisAlexandre Todorovic Fabro, Luka Brcic, Rosane Duarte Achcar
Archives of Pathology & Laboratory Medicine|March 7, 2018
Reproducibility of Malignant Pleural Mesothelioma Histopathologic SubtypingLuka Brcic, Gregor Vlacic, Franz Quehenberger, et al.
BMC Cancer|July 7, 2018
Bulk tumour cell migration in lung carcinomas might be more common than epithelial-mesenchymal transition and be differently regulatedMartin Zacharias, Luka Brcic, Sylvia Eidenhammer, et al.
Archives of Pathology & Laboratory Medicine|November 9, 2018
In ReplyLuka Brcic, Gregor Vlacic, Franz Quehenberger, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 5, 2024
Detection of antibody subclasses IgA, IgM and IgG against HPV L1 in HPV-positive oropharyngeal squamous cell carcinoma patients: a pilot studyThomas Weiland, Jakob Zgubic, Luka Brcic, et al.
Advances in Anatomic Pathology|May 8, 2024
From Morphology to Molecules: Advances in the Distinction of Multiple Primary Lung Cancers From Intrapulmonary Metastases in Non-Small Cell Lung CancerGheorghe-Emilian Olteanu, Izidor Kern, Lipika Kalson, et al.
Rheumatology International|October 4, 2021
Lung fibrosis in autoimmune diseases and hypersensitivity: how to separate these from idiopathic pulmonary fibrosisHelmut Popper, Elvira Stacher-Priehse, Luka Brcic, et al.
Ebiomedicine|November 30, 2020
Response to: "Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test"Thomas Weiland, Luka Brcic, Markus Reinholz, et al.
Clinical Nuclear Medicine|December 5, 2022
18F-FDG PET/CT in Primary Mesothelioma of the LiverBirgit Pernthaler, Luka Brcic, Reingard Maria Aigner, et al.
Lung Cancer (Amsterdam, Netherlands)|June 24, 2022
DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomasPhilipp Jurmeister, Maximilian Leitheiser, Peggy Wolkenstein, et al.
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Frontiers in Medicine|April 23, 2025
Editorial: Biomarkers for progressive pulmonary fibrosisAlexandre Todorovic Fabro, Luka Brcic, Rosane Duarte Achcar
Archives of Pathology & Laboratory Medicine|March 7, 2018
Reproducibility of Malignant Pleural Mesothelioma Histopathologic SubtypingLuka Brcic, Gregor Vlacic, Franz Quehenberger, et al.
BMC Cancer|July 7, 2018
Bulk tumour cell migration in lung carcinomas might be more common than epithelial-mesenchymal transition and be differently regulatedMartin Zacharias, Luka Brcic, Sylvia Eidenhammer, et al.
Archives of Pathology & Laboratory Medicine|November 9, 2018
In ReplyLuka Brcic, Gregor Vlacic, Franz Quehenberger, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|March 5, 2024
Detection of antibody subclasses IgA, IgM and IgG against HPV L1 in HPV-positive oropharyngeal squamous cell carcinoma patients: a pilot studyThomas Weiland, Jakob Zgubic, Luka Brcic, et al.
Advances in Anatomic Pathology|May 8, 2024
From Morphology to Molecules: Advances in the Distinction of Multiple Primary Lung Cancers From Intrapulmonary Metastases in Non-Small Cell Lung CancerGheorghe-Emilian Olteanu, Izidor Kern, Lipika Kalson, et al.
Rheumatology International|October 4, 2021
Lung fibrosis in autoimmune diseases and hypersensitivity: how to separate these from idiopathic pulmonary fibrosisHelmut Popper, Elvira Stacher-Priehse, Luka Brcic, et al.
Ebiomedicine|November 30, 2020
Response to: "Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test"Thomas Weiland, Luka Brcic, Markus Reinholz, et al.
Clinical Nuclear Medicine|December 5, 2022
18F-FDG PET/CT in Primary Mesothelioma of the LiverBirgit Pernthaler, Luka Brcic, Reingard Maria Aigner, et al.
Lung Cancer (Amsterdam, Netherlands)|June 24, 2022
DNA methylation-based machine learning classification distinguishes pleural mesothelioma from chronic pleuritis, pleural carcinosis, and pleomorphic lung carcinomasPhilipp Jurmeister, Maximilian Leitheiser, Peggy Wolkenstein, et al.
Pageof 17